For example, we have recently shown that one frequent mutation in the resistant CLL, PLCγ2 R665W, is likely to stabilize an active form by affecting allosteric networks to facilitate binding of the phosphorylated peptide to the cSH2 domain [34]. The gene discussed is PLCG2; the disease is B-cell chronic lymphocytic leukemia.